261 related articles for article (PubMed ID: 17475445)
1. Pulmonary endothelial cell barrier enhancement by FTY720 does not require the S1P1 receptor.
Dudek SM; Camp SM; Chiang ET; Singleton PA; Usatyuk PV; Zhao Y; Natarajan V; Garcia JG
Cell Signal; 2007 Aug; 19(8):1754-64. PubMed ID: 17475445
[TBL] [Abstract][Full Text] [Related]
2. Junctional complex and focal adhesion rearrangement mediates pulmonary endothelial barrier enhancement by FTY720 S-phosphonate.
Wang L; Bittman R; Garcia JG; Dudek SM
Microvasc Res; 2015 May; 99():102-9. PubMed ID: 25862132
[TBL] [Abstract][Full Text] [Related]
3. Activated protein C mediates novel lung endothelial barrier enhancement: role of sphingosine 1-phosphate receptor transactivation.
Finigan JH; Dudek SM; Singleton PA; Chiang ET; Jacobson JR; Camp SM; Ye SQ; Garcia JG
J Biol Chem; 2005 Apr; 280(17):17286-93. PubMed ID: 15710622
[TBL] [Abstract][Full Text] [Related]
4. Differential involvement of ezrin/radixin/moesin proteins in sphingosine 1-phosphate-induced human pulmonary endothelial cell barrier enhancement.
Adyshev DM; Moldobaeva NK; Elangovan VR; Garcia JG; Dudek SM
Cell Signal; 2011 Dec; 23(12):2086-96. PubMed ID: 21864676
[TBL] [Abstract][Full Text] [Related]
5. Photolysis of caged sphingosine-1-phosphate induces barrier enhancement and intracellular activation of lung endothelial cell signaling pathways.
Usatyuk PV; He D; Bindokas V; Gorshkova IA; Berdyshev EV; Garcia JG; Natarajan V
Am J Physiol Lung Cell Mol Physiol; 2011 Jun; 300(6):L840-50. PubMed ID: 21478254
[TBL] [Abstract][Full Text] [Related]
6. Pulmonary endothelial cell barrier enhancement by novel FTY720 analogs: methoxy-FTY720, fluoro-FTY720, and β-glucuronide-FTY720.
Camp SM; Chiang ET; Sun C; Usatyuk PV; Bittman R; Natarajan V; Garcia JG; Dudek SM
Chem Phys Lipids; 2015 Oct; 191():16-24. PubMed ID: 26272033
[TBL] [Abstract][Full Text] [Related]
7. Regulation of sphingosine 1-phosphate-induced endothelial cytoskeletal rearrangement and barrier enhancement by S1P1 receptor, PI3 kinase, Tiam1/Rac1, and alpha-actinin.
Singleton PA; Dudek SM; Chiang ET; Garcia JG
FASEB J; 2005 Oct; 19(12):1646-56. PubMed ID: 16195373
[TBL] [Abstract][Full Text] [Related]
8. Endothelial barrier protection by FTY720 under hyperglycemic condition: involvement of focal adhesion kinase, small GTPases, and adherens junction proteins.
Sarai K; Shikata K; Shikata Y; Omori K; Watanabe N; Sasaki M; Nishishita S; Wada J; Goda N; Kataoka N; Makino H
Am J Physiol Cell Physiol; 2009 Oct; 297(4):C945-54. PubMed ID: 19657053
[TBL] [Abstract][Full Text] [Related]
9. "Pulmonary Endothelial Cell Barrier Enhancement by Novel FTY720 Analogs: Methoxy-FTY720, Fluoro-FTY720, and β-Glucuronide-FTY720".
Camp SM; Chiang ET; Sun C; Usatyuk PV; Bittman R; Natarajan V; Garcia JG; Dudek SM
Chem Phys Lipids; 2016 Jan; 194():85-93. PubMed ID: 26496151
[TBL] [Abstract][Full Text] [Related]
10. FTY720-induced human pulmonary endothelial barrier enhancement is mediated by c-Abl.
Wang L; Chiang ET; Simmons JT; Garcia JG; Dudek SM
Eur Respir J; 2011 Jul; 38(1):78-88. PubMed ID: 21071472
[TBL] [Abstract][Full Text] [Related]
11. Synthetic analogs of FTY720 [2-amino-2-(2-[4-octylphenyl]ethyl)-1,3-propanediol] differentially regulate pulmonary vascular permeability in vivo and in vitro.
Camp SM; Bittman R; Chiang ET; Moreno-Vinasco L; Mirzapoiazova T; Sammani S; Lu X; Sun C; Harbeck M; Roe M; Natarajan V; Garcia JG; Dudek SM
J Pharmacol Exp Ther; 2009 Oct; 331(1):54-64. PubMed ID: 19592667
[TBL] [Abstract][Full Text] [Related]
12. Transactivation of sphingosine 1-phosphate receptors is essential for vascular barrier regulation. Novel role for hyaluronan and CD44 receptor family.
Singleton PA; Dudek SM; Ma SF; Garcia JG
J Biol Chem; 2006 Nov; 281(45):34381-93. PubMed ID: 16963454
[TBL] [Abstract][Full Text] [Related]
13. FTY720 (s)-phosphonate preserves sphingosine 1-phosphate receptor 1 expression and exhibits superior barrier protection to FTY720 in acute lung injury.
Wang L; Sammani S; Moreno-Vinasco L; Letsiou E; Wang T; Camp SM; Bittman R; Garcia JG; Dudek SM
Crit Care Med; 2014 Mar; 42(3):e189-99. PubMed ID: 24335440
[TBL] [Abstract][Full Text] [Related]
14. Akt-mediated transactivation of the S1P1 receptor in caveolin-enriched microdomains regulates endothelial barrier enhancement by oxidized phospholipids.
Singleton PA; Chatchavalvanich S; Fu P; Xing J; Birukova AA; Fortune JA; Klibanov AM; Garcia JG; Birukov KG
Circ Res; 2009 Apr; 104(8):978-86. PubMed ID: 19286607
[TBL] [Abstract][Full Text] [Related]
15. Pulmonary endothelial cell barrier enhancement by sphingosine 1-phosphate: roles for cortactin and myosin light chain kinase.
Dudek SM; Jacobson JR; Chiang ET; Birukov KG; Wang P; Zhan X; Garcia JG
J Biol Chem; 2004 Jun; 279(23):24692-700. PubMed ID: 15056655
[TBL] [Abstract][Full Text] [Related]
16. Sphingosine-1-phosphate agonists increase macrophage homing, lymphocyte contacts, and endothelial junctional complex formation in murine lymph nodes.
Singer II; Tian M; Wickham LA; Lin J; Matheravidathu SS; Forrest MJ; Mandala S; Quackenbush EJ
J Immunol; 2005 Dec; 175(11):7151-61. PubMed ID: 16301618
[TBL] [Abstract][Full Text] [Related]
17. Immunosuppressive and anti-angiogenic sphingosine 1-phosphate receptor-1 agonists induce ubiquitinylation and proteasomal degradation of the receptor.
Oo ML; Thangada S; Wu MT; Liu CH; Macdonald TL; Lynch KR; Lin CY; Hla T
J Biol Chem; 2007 Mar; 282(12):9082-9. PubMed ID: 17237497
[TBL] [Abstract][Full Text] [Related]
18. Antagonism of sphingosine-1-phosphate receptors by FTY720 inhibits angiogenesis and tumor vascularization.
LaMontagne K; Littlewood-Evans A; Schnell C; O'Reilly T; Wyder L; Sanchez T; Probst B; Butler J; Wood A; Liau G; Billy E; Theuer A; Hla T; Wood J
Cancer Res; 2006 Jan; 66(1):221-31. PubMed ID: 16397235
[TBL] [Abstract][Full Text] [Related]
19. Functional characterization of sphingosine 1-phosphate receptor agonist in human endothelial cells.
Butler J; Lana D; Round O; LaMontagne K
Prostaglandins Other Lipid Mediat; 2004 Jan; 73(1-2):29-45. PubMed ID: 15165029
[TBL] [Abstract][Full Text] [Related]
20. FTY720 postconditions isolated perfused heart by a mechanism independent of sphingosine kinase 2 and different from S1P or ischemic postconditioning.
Vessey DA; Li L; Imhof I; Honbo N; Karliner JS
Med Sci Monit Basic Res; 2013 Apr; 19():126-32. PubMed ID: 23567658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
